Sartorius Stedim Biotech S.A. (LON:0RG8)
173.55
-4.45 (-2.50%)
At close: Feb 11, 2026
Sartorius Stedim Biotech Revenue
Sartorius Stedim Biotech had revenue of 705.70M EUR in the quarter ending September 30, 2025, with 7.67% growth. This brings the company's revenue in the last twelve months to 2.95B, up 7.72% year-over-year. In the year 2024, Sartorius Stedim Biotech had annual revenue of 2.78B with 0.16% growth.
Revenue (ttm)
2.95B EUR
Revenue Growth
+7.72%
P/S Ratio
5.71
Revenue / Employee
290.76K EUR
Employees
10,134
Market Cap
14.68B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.78B | 4.50M | 0.16% |
| Dec 31, 2023 | 2.78B | -717.20M | -20.53% |
| Dec 31, 2022 | 3.49B | 605.70M | 20.98% |
| Dec 31, 2021 | 2.89B | 976.92M | 51.15% |
| Dec 31, 2020 | 1.91B | 469.51M | 32.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aviva | 24.26B |
| Aviva | 24.26B |
| Associated British Foods | 19.46B |
| Legal & General Group | 12.45B |
| Coca-Cola HBC AG | 10.12B |
| NEXT plc | 6.40B |
| Rentokil Initial | 5.51B |
| Airtel Africa | 4.47B |